Levosimendan in Patients with Low Cardiac Output Syndrome After Cardiac Surgery: A Substudy of the Multicenter Randomized CHEETAH Trial.

cardiac surgery cardiopulmonary bypass levosimendan low cardiac output syndrome

Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
10 Oct 2024
Historique:
received: 07 07 2024
revised: 03 09 2024
accepted: 01 10 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 31 10 2024
Statut: aheadofprint

Résumé

To test the hypothesis that levosimendan administration in patients with low cardiac output syndrome after cardiac surgery is associated with improved long-term (5-year follow-up) outcomes. Single-center subanalysis of the multicenter randomized CHEETAH trial. Cardiac surgery department of a tertiary hospital. A total of 134 adult patients requiring hemodynamic support for a cardiac index <2.5 L/min/m Patients were randomized (1:1 ratio) to receive levosimendan (continuous infusion with a starting dose of 0.05 μg/kg/min) or placebo, in addition to standard inotropic care. The primary endpoint was long-term mortality (1-5 years) after randomization. Secondary outcomes were hemodynamic parameters, need for inotropic support, acute kidney injury (AKI), need for renal replacement therapy, duration of mechanical ventilation, intensive care unit (ICU) and hospital stay, and 30-day mortality. No significant between-group difference in long-term mortality (5 years) was observed (hazard ratio, 1.59; 95% confidence interval, 0.81 to 3.11; p = 0.17). There were no significant differences in secondary outcomes, except for the difference in the mean pulmonary artery pressure at 4 to 6 hours after randomization, which was lower in the levosimendan group compared to the placebo group (median, 24 [interquartile range (IQR), 21.8-28] mmHg vs 26 [IQR, 22.2-33] mmHg; p = 0.019). Among patients requiring hemodynamic support after cardiac surgery with CPB, perioperative levosimendan infusion did not affect long-term survival (1-5 years) compared with placebo. Levosimendan also had no effect on major clinical outcomes such as AKI, ICU stay, hospital stay, and 30-day mortality.

Identifiants

pubmed: 39482169
pii: S1053-0770(24)00785-7
doi: 10.1053/j.jvca.2024.10.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Vladimir Boboshko (V)

Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center, Novosibirsk, Russia. Electronic address: vaboboshko@gmail.com.

Vladimir Lomivorotov (V)

Department of Anesthesiology and Perioperative Medicine, Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA.

Pavel Ruzankin (P)

Department of Mathematics and Mechanics, Novosibirsk State University, Novosibirsk, Russia; Sobolev Institute of Mathematics, Novosibirsk, Russia.

Sergey Khrushchev (S)

Sobolev Institute of Mathematics, Novosibirsk, Russia.

Liudmila Lomivorotova (L)

Department of Anesthesiology and Intensive Care, E. Meshalkin National Medical Research Center, Novosibirsk, Russia.

Fabrizio Monaco (F)

Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Maria Grazia Calabrò (MG)

Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Marco Comis (M)

Cardiac and Vascular Department, Ospedale Mauriziano Umberto I, Torino, Italy.

Tiziana Bove (T)

Department of Medicine (DMED), University of Udine, Italy; Department of Emergency "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine University Hospital, Udine, Italy.

Antonio Pisano (A)

Cardiac Anesthesia and ICU, AORN "Dei Colli", Monaldi Hospital, Naples, Italy.

Alessandro Belletti (A)

Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Classifications MeSH